Phase I Study of Nivolumab, an Anti-Pd-1 Antibody, in Patients With Malignant Solid Tumors
Investigational New Drugs - Netherlands
doi 10.1007/s10637-016-0411-2
Full Text
Open PDFAbstract
Available in full text
Date
December 8, 2016
Authors
Publisher
Springer Science and Business Media LLC